Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of quisinostat in combination with chemotherapy in patients with non…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating first-line paclitaxel (Taxol) plus carboplatin for epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand [NA]
A completed surgical trial comparing LIGASURE-assisted recto-sigmoid resection with omentectomy to the standard approach in epithelial ovari…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating the combination of birinapant and conatumumab in relapsed ovarian and related cancers has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial adding AMG 479 to first-line chemotherapy for optimally debulked epithelial ovarian cancer was terminated, with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial comparing CAELYX (pegylated liposomal doxorubicin) to topotecan hydrochloride in recurrent epithelial ovarian cancer after fai…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy [Phase 3]
A Phase 3 trial comparing carboplatin alone versus carboplatin with gemcitabine in patients with advanced epithelial ovarian cancer that has…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) [NA]
Multinational Phase III randomized trial CALYPSO comparing pegylated liposomal doxorubicin (CAELYX) with carboplatin vs paclitaxel with carb…
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR [Phase 1]
A Phase 1 trial evaluated AMG-386 in combination with either pegylated liposomal doxorubicin or topotecan in advanced recurrent epithelial o…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer [Phase 2]
Phase 2 trial of birinapant in advanced epithelial ovarian, fallopian tube, and peritoneal cancers was terminated; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment [Phase 1, Phase 2]
Phase 1/2 study evaluating belinostat in combination with carboplatin and/or paclitaxel in relapsed ovarian cancer; results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine [Phase 1]
Phase 1 study evaluating conditioning with cyclophosphamide or denileukin diftitox followed by expansion of the patient’s own T cells for HE…
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer [NA]
The clinical trial evaluating Seprafilm for preventing intraperitoneal adhesions and improving delivery of intraperitoneal chemotherapy in w…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Safety Study of Farletuzumab, Carboplatin and Pegylated Liposomal Doxorubicin (PLD) to Treat Platinum-sensitive Ovarian Cancer [Phase 1]
Phase 1 safety study evaluating a combination of farletuzumab, carboplatin, and pegylated liposomal doxorubicin for platinum-sensitive epith…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer [Phase 3]
This Phase 3 trial evaluated early post-operative enteral feeding in patients with advanced epithelial ovarian cancer, including peritoneal …
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Study of Paclitaxel in Patients With Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating paclitaxel in patients with epithelial ovarian cancer, primary peritoneal cancer, and fallopian tube cancer has c…
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 study evaluating lenalidomide (Revlimid) in combination with pegylated liposomal doxorubicin (Doxil) and bevacizumab (Avastin) in pl…
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2, single-arm trial evaluating BSI-201 in BRCA-associated advanced epithelial ovarian cancer, fallopian tube cancer, and primary perit…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer [Phase 2]
Phase 2 trial evaluating intravenous denileukin diftitox plus subcutaneous pegylated interferon-alpha-2a in Stage III/IV ovarian-related can…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial update on thalidomide for patients with refractory or resistant epithelial ovarian cancer. The trial status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2013-05-10Clinical Trial Update: Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study [NA]
A feasibility study on hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer was terminated; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer [Phase 1]
Phase I trial evaluating ovarian cancer peptides plus GM-CSF as adjuvant therapy for epithelial ovarian cancer, fallopian tube cancer, or pe…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type [Phase 2]
Phase 2 trial of panitumumab plus pegylated liposomal doxorubicin for platinum-resistant epithelial ovarian cancer with KRAS wild-type has c…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer [Phase 2]
A Phase 2 trial update evaluating intravenous denileukin diftitox in stage III/IV ovarian cancer (epithelial ovarian cancer, extraovarian pe…
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer [Phase 2]
Phase II study evaluating intra- and postoperative administration of the trifunctional antibody catumaxomab in ovarian cancer has completed.